Astrava Biosciences is building ASTRA-Tx, a cross-species and cross-environment drug translation platform.

We use space pharmacology to study how medicines perform under microgravity, radiation, altered physiology, and other extreme environmental stressors—generating insights that can improve drug development both in space and on Earth.

• ASTRA-Tx — cross-species and cross-environment drug translation
• Space pharmacology — studying drug behavior beyond conventional terrestrial models
• Autonomous orbital laboratories — scalable experimentation in microgravity
• AI-enabled translation — connecting biological data across species, environments, and disease models
• Small-molecule programs — advancing new therapeutic opportunities

Our work spans:

• Microgravity drug development
• Cross-species translation
• Space-enabled biomedical research
• AI-assisted drug discovery
• Small-molecule therapeutics
• Long-duration mission medicine

Read our latest perspectives on space pharmacology, microgravity drug development, autonomous orbital laboratories, and the future of medicine beyond Earth.

We welcome conversations with researchers, pharmaceutical companies, spaceflight partners, investors, and mission-driven collaborators.

• Website: astrava.bio
• Email: info@astrava.bio